E-cadherin Is a WT1 Target Gene
Open Access
- 1 April 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (15) , 10943-10953
- https://doi.org/10.1074/jbc.275.15.10943
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Inhibition of Cellular Proliferation by the Wilms’ Tumor Suppressor WT1 Is Associated with Suppression of Insulin-Like Growth Factor I Receptor Gene ExpressionMolecular and Cellular Biology, 1995
- Sequence and structural requirements for high-affinity DNA binding by the WT1 gene productMolecular and Cellular Biology, 1995
- High affinity binding sites for the Wilms’ tumour suppressor protein WT1Nucleic Acids Research, 1995
- WT1 -Mediated Growth Suppression of Wilms Tumor Cells Expressing a WT1 Splicing VariantScience, 1993
- A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1.Proceedings of the National Academy of Sciences, 1993
- WT-1 is required for early kidney developmentCell, 1993
- Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1Science, 1992
- Binding of the Wilms' Tumor Locus Zinc Finger Protein to the EGR-1 Consensus SequenceScience, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Nephrogenic Rests, Nephroblastomatosis, and the Pathogenesis of Wilms' TumorPediatric Pathology, 1990